Mental Health DailyResearch. Evidence. Perspective.Published research on allopregnanolone.
Resting-state fMRI studies of postpartum depression have produced inconsistent results for years. A 2026 voxel-based meta-analysis pooled 12 studies of 475 patients and found 4 reliable regi…
Read articleZuranolone, a novel antidepressant, shows promise in treating depression, as evidenced by a recent meta-analysis. A new study investigated zuranolone’s efficacy and safety, focusing on short…
Read articleAllopregnanolone agonists represent a promising new class of medications for treating depressive disorders. Evidence suggests that allopregnanolone agonists exhibit rapid-onset of antidepres…
Read articlePMS (Premenstrual Syndrome) is a condition characterized by unwanted symptoms such as mood swings, fatigue, food cravings, irritability, and depression. These symptoms tend to occur during t…
Read article
